BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2000
View Archived Issues
5-HT1A receptor agonist MKC-242 has antiaggressive activity in isolated mice
Read More
Ro-60-0175 exerts differential effects in combination with antidepressants in mouse model
Read More
Photofrin approved in Sweden, Ireland and Italy
Read More
Maxim submits NDA for Maxamine
Read More
Innohep approved by FDA for DVT
Read More
Arsenic trioxide receives third orphan drug designation from FDA
Read More
Nucleotides in development at Inspire for various clinical indications
Read More
Inhibitors of fungal chitin synthase a focus of research at Roche
Read More
SM-20550 provides protection against I/R-induced skeletal muscle injury
Read More
Role of vasopressin and vasopressin antagonists in heart failure reviewed at recent congress
Read More
Centaur completes enrollment in phase IIa Parkinson's disease trial
Read More
Added benefit of ET blockade and angiotensin receptor antagonism in CHF
Read More
M-Vax now available in Australia for melanoma therapy
Read More
Emivirine may be useful for preventing perinatal transmission of HIV, as reported at AIDS conference
Read More
Micrologix Biotech advances additional products into clinical trials
Read More
HIV-1 RT dimer destabilization as a target for new antiviral agents
Read More
Potent anti-HIV activity described for human lysozyme fragments at AIDS conference
Read More
Genzyme General files MAA for approval of Fabrazyme in Europe
Read More
EMEA accepts MAA for Replagal as treatment of Fabry disease
Read More
Design and characterization of low-affinity, short-acting A2A AdoR agonists
Read More
ZymoGenetics isolates new PDGF-alpha receptor-binding polypeptide
Read More
Triazolo CCR3 receptor antagonists claimed by Toray for Rx of allergic diseases, etc.
Read More
Banyu presents new heterocyclic ORL1 receptor antagonists, their preparation and use
Read More
Indena's new colchicine derivatives active against multidrug-resistant cancer cells
Read More
K-5993: a new peptide IL-4 antagonist
Read More
Novel series of antioxidants emerges from R&D at ADIR
Read More
Novel COMT inhibitors for Parkinson's disease under study at Portela
Read More
Antisense modulators of EGR-1 expression patented by Isis
Read More